Pricing Log in Create free account

Disc Medicine, Inc. (IRON) vs Xenon Pharmaceuticals Inc. (XENE)

Disc Medicine, Inc. and Xenon Pharmaceuticals Inc. are both Biotechnology companies. Disc Medicine, Inc. and Xenon Pharmaceuticals Inc. are of similar size ($3.7B and $3.5B). Across the 11 metrics below, Disc Medicine, Inc. leads on 6 and Xenon Pharmaceuticals Inc. on 5.

Valuation

Metric IRON XENE Biotechnology median
P/E n/m n/m 10.26
P/S n/m 222.58 9.18
P/B 4.74 3.03 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 169.19 8.98
Earnings yield (8.33%) (12.53%) (34.89%)
Free cash flow yield (6.50%) (8.98%) (24.52%)

Profitability

Metric IRON XENE Biotechnology median
Gross margin 0.00% 28.40% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (39.08%) (43.62%) (50.12%)
Return on assets (35.12%) (41.54%) (45.60%)
Return on invested capital 0.00% (88.54%) 0.00%

Growth

Metric IRON XENE Biotechnology median
Revenue growth (TTM) — (8.15%) 6.26%
EPS growth (last fiscal year) (51.77%) (44.85%) 29.88%
Revenue growth, 5-year CAGR — 89.00% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IRON XENE Biotechnology median
Debt to equity 0.09 0.00 0.00
Current ratio 24.14 21.02 4.89
Net debt to EBITDA 3.12 1.48 1.01

Dividend

Metric IRON XENE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IRON XENE Biotechnology median
Market cap 3.48b 3.65b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack